Use of Anti-IL-20 antibody for treating rheumatoid arthrits and osteoporosis

Ming-Shi Chang (Inventor)

研究成果: Patent

摘要

Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.
原文English
專利號8206712
出版狀態Published - 2011 一月 6

指紋

Osteoporosis
Rheumatoid Arthritis
Peptides
Antibodies
interleukin 20
Etanercept

引用此文

@misc{adecc98f23914aec95ac273f62324d2c,
title = "Use of Anti-IL-20 antibody for treating rheumatoid arthrits and osteoporosis",
abstract = "Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.",
author = "Ming-Shi Chang",
year = "2011",
month = "1",
day = "6",
language = "English",
type = "Patent",
note = "8206712",

}

TY - PAT

T1 - Use of Anti-IL-20 antibody for treating rheumatoid arthrits and osteoporosis

AU - Chang, Ming-Shi

PY - 2011/1/6

Y1 - 2011/1/6

N2 - Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.

AB - Treatment of rheumatoid arthritis and osteoporosis using an anti-IL-20 antibody 7E, and optionally, in combination with an etanercept polypeptide.

M3 - Patent

M1 - 8206712

ER -